Latest News
Regenx Biosciences and Avexis Enter into Agreement for The Development of Treatments for Spinal Muscular Atrophy Using NavRaav9 Vectors
Originally published on April 1, 2014. REGENX Biosciences, LLC and AveXis, Inc. announce that they have entered into an exclusive agreement for the development and commercialization of products to treat […]
Read More ›Cure Spinal Muscular Atrophy is Currently Funding 24 Research Projects with Multiple Rounds of New Funding to be Announced in 2014
Originally published on April 24, 2014. Cure SMA invests in four research areas: Basic Research, Drug Discovery, Clinical Research, and Care Research. Cure SMA has invested $35 Million in research […]
Read More ›Cure SMA Awarded Grant from the National Institute of Health for the 2014 Spinal Muscular Atrophy Research Group Meeting
Originally published on May 28, 2014. Cure SMA has been awarded a grant from The National Institute of Neurological Disorders and Disease (NINDS) and the Office of Rare Disease Research […]
Read More ›SMART Gives $50,000 to Cure SMA to Support Research
Based in Buffalo, NY, the Spinal Muscular Atrophy Research Team (SMART) is a grass roots organization started in 2009 to raise awareness and funds for research aimed at finding a […]
Read More ›Cure SMA Releases a Request for Proposals for New Funding of Research Projects for Spinal Muscular Atrophy.
Originally published on July 9, 2014. Cure SMA is pleased to announce that we are accepting grant applications for funding of research projects, under a competitive review by our Scientific […]
Read More ›Cure SMA Releases a New Request for Proposals for Clinical Care Research Projects in Spinal Muscular Atrophy
Originally published on July 16, 2014. Cure Spinal Muscular Atrophy (SMA) is pleased to announce that we are accepting applications for 2014 funding of clinical care research projects, under a […]
Read More ›